Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–79
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Inclusion:
Patients and subjects between 18-79 years old.
End stage renal patients who are consistently receiving dialysis for a minimum of 3.5 hours, three times per week, with hemodialysis blood flow rates of \>200mL/min may be eligible to enter the study.
Patients must also have systolic blood pressure 100-190mmHg and diastolic blood pressure \<120mmHg.
Healthy subjects must have systolic blood pressure 100-150mmHg.
Exclusion:
Female subjects who are pregnant and/or breast-feeding must not participate in this study.
Clareo Health | A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole
